Showing results (101-110 of 625) with videos related to
Sort By:
Pageof 63
Journal of Hematology & Oncology|December 23, 2018
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in BeijingZihai Li, Wenru Song, Mark Rubinstein, et al.Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|November 30, 2020
[A follow-Up Study with the Video Head Impulse Test for the patients with vestibular neuritis]Qing Yuan, Xinying Li, Yue Zhang, et al.Stem Cell Investigation|July 1, 2016
Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screeningKeyur Thakar, Kaushal Parikh, Yamei Chen, et al.Organic Letters|August 4, 2017
Synthesis of Chiral α,β-Unsaturated γ-Amino Esters via Pd-Catalyzed Asymmetric Allylic AminationChao Xia, Jiefeng Shen, Delong Liu, et al.Journal of Hematology & Oncology|August 2, 2015
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapyJingjing Wu, Jiaping Fu, Mingzhi Zhang, et al.Biomarker Research|November 21, 2013
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical applicationMuhammad Furqan, Nikhil Mukhi, Byung Lee, et al.Organic Letters|January 16, 2026
RuPHOX-Ru-Catalyzed Asymmetric Chemoselective Hydrogenation of α-Methylene-γ/δ-carbonyl Carboxylic AcidsJingli He, Wenqi Xu, Delong Liu, et al.Chemical Communications (Cambridge, England)|June 26, 2015
Iridium-catalyzed allyl-allyl cross-coupling of allylic carbonates with (E)-1,3-diarylpropenesQianjia Yuan, Kun Yao, Delong Liu, et al.Bioinformatics (Oxford, England)|April 17, 2004
A geometric approach to determine association and coherence of the activation times of cell-cycling genes under differing experimental conditionsDelong Liu, Clarice R Weinberg, Shyamal D PeddadaJournal of Hematology & Oncology|September 5, 2015
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemiaJingjing Wu, Jiaping Fu, Mingzhi Zhang, et al.Pageof 63